2,3-diphosphoglycerate affects enzymes of glucose metabolism in red blood cells.
D001786:Blood Glucose / Q000378:metabolism*; D004912:Erythrocytes / Q000187:drug effects / Q000201:enzymology* / Q000378:metabolism; D005634:Fructose-Bisphosphate Aldolase / Q000037:antagonists & inhibitors; D005987:Glyceraldehyde-3-Phosphate Dehydrogenases / Q000037:antagonists & inhibitors; D005994:Glycerophosphates / Q000494:pharmacology*; D006593:Hexokinase / Q000037:antagonists & inhibitors; D006801:Humans; D066298:In Vitro Techniques; D008274:Magnesium / Q000494:pharmacology; D010732:Phosphofructokinase-1 / Q000037:antagonists & inhibitors; D010733:Phosphoglucomutase / Q000037:antagonists & inhibitors
D001786:Blood Glucose; D005994:Glycerophosphates; D005987:Glyceraldehyde-3-Phosphate Dehydrogenases; D006593:Hexokinase; D010732:Phosphofructokinase-1; D005634:Fructose-Bisphosphate Aldolase; D010733:Phosphoglucomutase; D008274:Magnesium